Bicycle Therapeutics Change in Payables and Accrued Expense (Quarterly) Insights

Bicycle Therapeutics Plc (BCYC)

5.37 -0.17 (-3.07%) USD | NASDAQ | Feb 20, 16:00

5.365 0.00 (0.00%) Pre-Market: 20:00

View Change in Payables and Accrued Expense (Quarterly) for BCYC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Change in Payables and Accrued Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Change in Payables and Accrued Expense (Quarterly) Benchmarks

Start Trial

Biodexa Pharmaceuticals Plc	--
NuCana Plc	Upgrade
Mereo BioPharma Group Plc	Upgrade
Autolus Therapeutics Plc	Upgrade
DBV Technologies SA	Upgrade